Histopathological features of gastritis before and after treatment for Helicobacter pylori

被引:0
|
作者
Jakic-Razumovic, J
Tentor, D
Kusec, V
Cuzic, S
Brkic, T
机构
[1] Univ Zagreb, Ctr Hosp, Dept Clin Pathol, Zagreb 41000, Croatia
[2] Univ Zagreb, Ctr Hosp, Clin Inst Lab Diag, Zagreb 41000, Croatia
[3] Univ Zagreb, Ctr Hosp, Dept Internal Med, Zagreb 41000, Croatia
关键词
biopsy; campylobacter pylori; gastritis; atrophic; helicobacter infections; helicobacter pylori; metaplasia; intestinal; stomach diseases;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aim. To assess five main histological features of gastritis in gastric mucosa colonized with Helicobacter pylori before and after the treatment. Methods. Histologic assessment of H, pylori-associated gastritis was performed according to the Sydney classification before and after the treatment in 97 patients. Two additional parameters - the presence of lymphocytic aggregates and coccoid forms of bacteria - were also analyzed. Helical and coccoid forms of H. pylori were detected by immunohistochemistry in biopsies after the treatment. Results. Whereas acute epithelial damage was quickly repaired, some of the local responses to bacteria, e.g., lymphoid aggregates and intestinal metaplasia, persisted after treatment. Higher H. pylori and cocci density was found before and after treatment in patients with intestinal metaplasia (p = 0.020). Correlation between H. pylori and mucosal atrophy was found only after treatment (p = 0.009). Immunohistochemical staining was more sensitive in detecting of H. pylori than Giemsa staining (p = 0.007) in cases where, using only Giemsa staining, it was not possible to distinguish coccoid forms of H, pylori from other cocci. Conclusion. After treatment, H. pylori-associated gastritis showed reduction of acute and chronic inflammation, but lymphoid aggregates and intestinal metaplasia persisted. Immunohistochemistry of different forms of H. pylori may be a valuable technique in monitoring the success of the treatment.
引用
收藏
页码:159 / 162
页数:4
相关论文
共 50 条
  • [31] HELICOBACTER-PYLORI GASTRITIS AND RESPONSE TO TREATMENT
    HALLSTONE, AE
    GASTROENTEROLOGY, 1993, 104 (04) : A93 - A93
  • [32] Treatment of Helicobacter pylori in patients with lymphocytic gastritis
    Niemelä, S
    Karttunen, TJ
    Kerola, T
    HEPATO-GASTROENTEROLOGY, 2001, 48 (40) : 1176 - 1178
  • [33] Treatment of Helicobacter pylori infection in atrophic gastritis
    Edith Lahner
    Marilia Carabotti
    Bruno Annibale
    World Journal of Gastroenterology, 2018, (22) : 2373 - 2380
  • [34] The Number of Helicobacter pylori cagA EPIYA C Tyrosine Phosphorylation Motifs Is Associated with Histopathological Features of Chronic Gastritis
    Ferreira, Rui M.
    Machado, Jose C.
    Cameiro, Fatima
    Figueiredo, Ceu
    GASTROENTEROLOGY, 2009, 136 (05) : A549 - A549
  • [35] Histopathological Features of Helicobacter pylori Infection in Gastric Mucosa
    Wang, Yang-Kun
    Li, Chun
    Zhou, Yong-Mei
    Zeng, Lei
    Li, Ying-Ying
    Huang, Si-Lin
    Zhu, Chao-Ya
    Wang, Yue
    Wang, Su-Nan
    Chen, Xiao-Dong
    JOURNAL OF INFLAMMATION RESEARCH, 2022, 15 : 6231 - 6243
  • [36] Chemosusceptibility of Helicobacter pylori (HP) before and after unsuccessfull treatment
    Gatta, L
    Acciardi, C
    Landi, F
    Figura, N
    Ricci, C
    Menegatti, M
    Holton, J
    Miglioli, M
    Vaira, D
    GUT, 2000, 46 : A87 - A87
  • [37] How to detect Helicobacter pylori before and after eradication treatment
    Monteiro, L
    Mégraud, F
    GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE, 1999, 23 (10): : C3 - C19
  • [38] Apoptosis in Helicobacter pylori gastritis and residual gastritis after distal gastrectomy
    Tomonaga, K
    Takada, M
    Ichihara, T
    Kuroda, Y
    HEPATO-GASTROENTEROLOGY, 2003, 50 (52) : 902 - 905
  • [39] Duodenal Intraepithelial Lymphocytosis in Helicobacter pylori Gastritis: A Comparison after Treatment.
    Lloyd, K. A.
    Yeh, M. M.
    MODERN PATHOLOGY, 2011, 24 : 158A - 158A
  • [40] Role of Helicobacter pylori serology in atrophic body gastritis after eradication treatment
    Lahner, E
    Bordi, C
    Di Giulio, E
    Caruana, P
    D'Ambra, G
    Milione, M
    Grossi, C
    Delle Fave, G
    Annibale, B
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2002, 16 (03) : 507 - 514